| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-26 |
| filingDate |
2008-11-12^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6136609d7394a31a051c3f7923123781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b067f402e4c0c4939e67e09876ab19f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14bdfacaf325f6a43ab50f8f82da8ab |
| publicationDate |
2010-10-07^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2010256402-A1 |
| titleOfInvention |
Novel solvate |
| abstract |
The present invention relates to the novel crystalline form X of Tigecycline and to processes of preparing the same. Furthermore the present invention relates to the use of crystalline form X of Tigecycline as an intermediate for the preparation of an anti-infective medicament. Moreover the present invention relates to the use of crystalline form X of Tigecycline for the preparation of acid addition salts of Tigecycline |
| priorityDate |
2007-11-14^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |